Eden Research (LON:EDEN) Trading Down 3.3% – Should You Sell?

Eden Research plc (LON:EDEN) dropped 3.3% during mid-day trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares traded hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The business’s 50 day moving average is GBX 3.87 and its 200-day moving average is GBX 3.95. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The firm has a market capitalization of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92.

Insider Activity at Eden Research

In other news, insider Lykele van der Broek purchased 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The shares were purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,958.74). Also, insider Alexander John Abrey purchased 540,540 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,362.19). 14.02% of the stock is currently owned by insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.